Cascades has reported a sequential increase in its second-quarter 2024 results, with sales rising to $1,180 million from $1,109 million in the previous quarter. Operating income improved to $34 million, up from $9 million in Q1 2024, while net earnings per share reached $0.01, a recovery from the $0.20 loss per share in the previous quarter.
The company’s performance was bolstered by stronger results across its Tissue Papers, Specialty Products, and Containerboard segments, despite higher raw material costs and production downtime at key mills. Cascades expects continued growth in Q3 2024, driven by price increases and improved production efficiency.
Read the full financial results here.
Print this page
Advertisement
Stories continue below
Related
Tags
